KOAH Epidemiyolojisi

Kaynaklar1.Celi BR, MacNee W et al. Standarts for the diagnosis and treatment of patients withCOPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-9462. Saetta M. Airway inflammation in chronic obstructive pulmonary disease. Am JRespir Crit Care Med 1999;160:S17-S20.3.Snider FL. Defining chronic obstructive pulmonary disease. In: Clarverley P, Pride N(eds). Chronic Obstructive Pulmonary Disease. London: Chapman Hill Med; 1995:1-8.4. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonarydisease (COPD). Lancet 2004; 364: 613-6205.Coultas DB, Mapel DW. Undiagnosed airflow obstruction:prevalance andimplications. Curr Opin Pulm Med 2003; 9: 96-1036.Barnes PJ, Kleinert S. COPD-a neglected disease. Lancet 2004; 364: 564-5657.Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalance estimates.What is the true burden of disease. Chest 2003; 123: 1684-16928.Vollmer WM. Epidemiology of COPD: overview and the US perspective. Eur RespirJ 2003; 22: Supp 43: 1s-3s9.Mannino DM. Chronic obstructive pulmonary disease: definition and epidemiology.Respir Care 2003; 48: 1185-119110.Viegi G. Epidemiology of COPD: a European perspective. Eur Respir J 2003; 22:Supp 43:3s7s11.Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause1990-2020: Global burden of disease study. Lancet 1997;349:1498-150412.ERS: European Lung White Book. London, 2003: 34-4313.Baykal Y. Kronik obstrüktif akciğer hastalığı üzerinde epidemiyolojik bir araştırma.Tüberküloz ve Toraks 1976;24:3-18.14.Sağlık İstatistikleri 1964-1994. SB APK Dairesi Yayınları, Ankara; 1995.15. Kocabas A ve ark. BOLD-Adana çalısması (yayınlanmamış çalışma)16.Hansel TT, Barnes PJ. An atlas of chronic obstructive pulmonary disease(COPD).Parthenon Publishing Group, New York, 2004: 1-1917.Busset AS. Risk factors for COPD. Eur Respir Rev 1996;6:253-258.18.Wiedermann HP, Stoller JK. Lung disease due to alfa-1 antitrypsin deficiency.Current Opinion in Pulmonary Medicine 1996;2:155-160.19.Rijcken B, Britton J. Epidemiology of chronic obstructive pulmonary disease.European Respiratorş Monograph 1998;3:41-72.20.Molfino N. Genetics of COPD. Chest 2004; 125: 1929-194021.Gold DR, Wang MPHX, Wypij D et al. Effects of cigarette smoking on lungfunction in adolescent boys and girls. N Engl J Med 1996;335:931-937.22..Prescott E, Lange P, Vestbo J. Socieconomic status, lung function and admission tohospital for COPD. Eur Respir J 1999;13:1109-111423.Prescent E, Bjerg EM, Andersen PK et al. Gender difference in smoking effect onlung function and risk of hospitalization for COPD. Eur Respir J 1997;10:822-827.24. Hogg J. Latent adenoviral infections in the pathogenesis of COPD. Eur Respir Rev1997;7:216-22025. Niederman MS. Acute exacerbations of chronic bronchitis: The role of infection andthe selection of appropriate therapy. ACCH The Best of PCCU; 1997;11(lesson:27).26. Tashkin DP, Altose MD, Bleecker ER et al. The Lung Health Study: airwayresponsiviness to inhaled methacholine in smokers with mild to moderate airflowlimitation. Am Rev Respir Dis 1992;145:301-31027.Massaro GDC, Massora D. Retinoic acit treatment abrogates elastase-inducedpulmonary emphysema in rats. Nature Medicine 1997;3:675-677.